The U.S. Food and Drug Administration (FDA) will continue hosting a virtual Town Hall series for SARS-CoV-2 (COVID-19) test developers and will now also include information and answer questions about monkeypox test development. For each Town Hall, the FDA will indicate whether the session will address COVID-19, monkeypox, or both.
Registration is not necessary.
There will be an opportunity to ask questions live on the call, and questions may also be submitted in advance by emailing [email protected].
Please submit questions by Monday, September 26, 12 p.m. ET before the Wednesday virtual Town Hall.
In the subject line of the email, type type “Questions for the Virtual Town Hall Series - Test Development and Validation During Public Health Emergencies” and clearly indicate whether your question is about COVID-19 or monkeypox.
Save the Date:
The FDA will hold a virtual Town Hall for test developers from 12:05 p.m.-1 p.m. ET on:
September 28: Town Hall #93 (COVID-19 and Monkeypox)
